Nicotinamide
Generic name
Nicotinamide
Brand name
ATC Code
A11HA01
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Pyruvate dehydrogenase complex 1 |
|---|
|
| Hartnup disease |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Treatment by or after consultations with a paediatric specialist (metabolic disorders) who has experience using nicotinamide for this indication.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
OTHER PLAIN VITAMIN PREPARATIONS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Other plain vitamin preparations | ||
|---|---|---|
| A11HA05 | ||
| A11HA06 | ||
| A11HA02 | ||
| A11HA04 | ||
| A11HA03 | ||
| A11HA08 | ||
Reference
- Blau, Hoffmann, Leonard and Clarke, Physicians guide to the treatment and follow-up of metabolic diseases, Springer, 2006
Changes
Therapeutic Drug Monitoring
Overdose
